Correlation Between Verrica Pharmaceuticals and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Relay Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Relay Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Relay Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verrica and Relay is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Relay Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 4.36 times less return on investment than Relay Therapeutics. But when comparing it to its historical volatility, Verrica Pharmaceuticals is 1.35 times less risky than Relay Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Relay Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 426.00 in Relay Therapeutics on October 20, 2024 and sell it today you would earn a total of 20.00 from holding Relay Therapeutics or generate 4.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Verrica Pharmaceuticals vs. Relay Therapeutics
Performance |
Timeline |
Verrica Pharmaceuticals |
Relay Therapeutics |
Verrica Pharmaceuticals and Relay Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verrica Pharmaceuticals and Relay Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |